Resumen de acción PGHL
Procter & Gamble Health Limited se dedica a la fabricación y comercialización de productos farmacéuticos y químicos en India y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Recompensas
Análisis de riesgos
Competidores de Procter & Gamble Health Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4,700.50 |
| 52 Week High | ₹5,642.85 |
| 52 Week Low | ₹4,575.00 |
| Beta | 0.45 |
| 1 Month Change | -3.49% |
| 3 Month Change | -9.02% |
| 1 Year Change | 1.05% |
| 3 Year Change | -25.66% |
| 5 Year Change | 26.52% |
| Change since IPO | 1,105.41% |
Noticias y actualizaciones recientes
Recent updates
Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)
Feb 14
Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00
Sep 29Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 10Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)
Mar 30We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right
Nov 17Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50
Oct 23Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50
Oct 09Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit
Feb 16Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?
Oct 04Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock
May 10Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?
Mar 23Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 02Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?
Jan 31Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like
Jan 10
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?
Dec 19Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?
Dec 01Rentabilidad de los accionistas
| PGHL | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | -2.2% | -2.2% | -2.1% |
| 1Y | 1.0% | 55.3% | 45.3% |
Rentabilidad vs. Industria: PGHL obtuvo unos resultados inferiores a los del sector Indian Pharmaceuticals , que el año pasado arrojó un rendimiento del 30.3%.
Rentabilidad vs. Mercado: PGHL obtuvo unos resultados inferiores a los del mercado Indian, que fue del 34.6% el año pasado.
Volatilidad de los precios
| PGHL volatility | |
|---|---|
| PGHL Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: PGHL no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de PGHL (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1967 | 1,407 | Milind Thatte | www.pghealthindia.com |
Procter & Gamble Health Limited se dedica a la fabricación y comercialización de productos farmacéuticos y químicos en India y a escala internacional. La empresa suministra productos de venta libre, vitaminas, minerales y suplementos. Ofrece sus productos bajo las marcas Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen y Seven Seas.
Resumen de fundamentos de Procter & Gamble Health Limited
| Estadísticas fundamentales de PGHL | |
|---|---|
| Capitalización bursátil | ₹78.32b |
| Beneficios(TTM) | ₹2.27b |
| Ingresos (TTM) | ₹12.37b |
34.4x
Ratio precio-beneficio (PE)6.3x
Ratio precio-ventas (PS)¿Está PGHL sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de PGHL | |
|---|---|
| Ingresos | ₹12.37b |
| Coste de los ingresos | ₹3.93b |
| Beneficio bruto | ₹8.44b |
| Otros gastos | ₹6.17b |
| Beneficios | ₹2.27b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 02, 2024
| Beneficios por acción (BPA) | 136.54 |
| Margen bruto | 68.23% |
| Margen de beneficio neto | 18.32% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado PGHL a largo plazo?
Ver rendimiento histórico y comparativa